Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Mol Genet Metab. 2020 Oct 17;132(1):27–37. doi: 10.1016/j.ymgme.2020.10.007

Figure 7. Relative abundance of lipids in DPM2-mutant and control fibroblasts.

Figure 7.

Relative peak areas reflecting abundance of lysophosphatidic acid (LPA) and lysophosphatidylserine (LPS) from lipidomic analysis of fibroblasts from controls (blue) and the DPM2 patient (red) are shown as circles. The horizontal line indicates average values in each group.